STOCK TITAN

[8-K] Bausch + Lomb Corporation Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Bausch + Lomb announced significant debt refinancing activities on June 18, 2025. The company has priced an offering of €675 million senior secured floating rate notes due 2031, increased from the initially announced €600 million. The notes will be sold at 99.500% of principal value.

The company is also pursuing a refinancing package including a $2.325 billion new term B loan facility (increased from $2.2 billion) with Term SOFR + 4.25% interest rate, and a $800 million new revolving credit facility. These proceeds will be used to:

  • Repay outstanding borrowings under existing revolving credit facility
  • Refinance term A loans due 2027
  • Refinance term B loans due 2027
  • Pay related fees and expenses

The notes offering is expected to close on June 26, 2025, subject to customary conditions. The notes will be offered to qualified institutional buyers in the US under Rule 144A and internationally under Regulation S, with first-priority liens on assets securing the company's credit agreement.

Bausch + Lomb ha annunciato il 18 giugno 2025 importanti attività di rifinanziamento del debito. La società ha fissato il prezzo di un'emissione di obbligazioni senior garantite a tasso variabile per 675 milioni di euro con scadenza 2031, aumentata rispetto ai 600 milioni di euro inizialmente annunciati. Le obbligazioni saranno vendute al 99,500% del valore nominale.

La società sta inoltre perseguendo un pacchetto di rifinanziamento che include una nuova linea di prestito term B da 2,325 miliardi di dollari (incrementata rispetto ai 2,2 miliardi di dollari precedenti) con un tasso di interesse Term SOFR + 4,25%, e una nuova linea di credito revolving da 800 milioni di dollari. Questi fondi saranno utilizzati per:

  • Rimborsare i prestiti in essere sotto la linea di credito revolving esistente
  • Rifinanziare i prestiti term A in scadenza nel 2027
  • Rifinanziare i prestiti term B in scadenza nel 2027
  • Pagare le commissioni e le spese correlate

L'offerta delle obbligazioni è prevista per la chiusura il 26 giugno 2025, soggetta a condizioni consuete. Le obbligazioni saranno offerte a investitori istituzionali qualificati negli Stati Uniti ai sensi della Rule 144A e a livello internazionale secondo il Regulation S, con privilegi di primo grado sugli asset a garanzia dell'accordo di credito della società.

Bausch + Lomb anunció el 18 de junio de 2025 importantes actividades de refinanciamiento de deuda. La compañía ha fijado el precio de una emisión de notas senior garantizadas a tasa flotante por €675 millones con vencimiento en 2031, incrementado desde los €600 millones inicialmente anunciados. Las notas se venderán al 99.500% del valor nominal.

La empresa también está gestionando un paquete de refinanciamiento que incluye una nueva línea de préstamo a plazo B de $2.325 mil millones (incrementada desde $2.2 mil millones) con una tasa de interés Term SOFR + 4.25%, y una nueva línea de crédito revolvente de $800 millones. Estos fondos se utilizarán para:

  • Reembolsar préstamos pendientes bajo la línea de crédito revolvente existente
  • Refinanciar préstamos a plazo A con vencimiento en 2027
  • Refinanciar préstamos a plazo B con vencimiento en 2027
  • Pagar honorarios y gastos relacionados

Se espera que la oferta de notas cierre el 26 de junio de 2025, sujeta a condiciones habituales. Las notas se ofrecerán a compradores institucionales calificados en EE. UU. bajo la Regla 144A y a nivel internacional bajo el Reglamento S, con gravámenes prioritarios sobre los activos que aseguran el acuerdo crediticio de la compañía.

Bausch + Lomb은 2025년 6월 18일에 중요한 부채 재융자 활동을 발표했습니다. 회사는 2031년 만기 6억 7,500만 유로 규모의 선순위 담보 변동금리 채권 발행 가격을 기존 6억 유로에서 상향 조정하여 확정했습니다. 해당 채권은 액면가의 99.500%에 판매될 예정입니다.

또한 회사는 22억 5천만 달러에서 증액된 23억 2,500만 달러 규모의 신규 Term B 대출 시설 (이자율 Term SOFR + 4.25%)과 8억 달러 규모의 신규 리볼빙 신용 한도를 포함하는 재융자 패키지를 추진 중입니다. 이 자금은 다음 용도로 사용됩니다:

  • 기존 리볼빙 신용 한도 내 미지급 차입금 상환
  • 2027년 만기 Term A 대출 재융자
  • 2027년 만기 Term B 대출 재융자
  • 관련 수수료 및 비용 지급

채권 발행은 2025년 6월 26일에 마감될 예정이며, 통상적인 조건이 적용됩니다. 채권은 미국 내 Rule 144A에 따른 적격 기관 투자자에게, 국제적으로는 Regulation S에 따라 제공되며, 회사 신용 계약을 담보하는 자산에 대해 우선 담보권이 설정됩니다.

Bausch + Lomb a annoncé le 18 juin 2025 d'importantes opérations de refinancement de dette. La société a fixé le prix d'une émission de 675 millions d'euros de billets seniors garantis à taux variable échéance 2031, portée à 675 millions d'euros contre 600 millions initialement annoncés. Les billets seront vendus à 99,500 % de leur valeur nominale.

La société poursuit également un plan de refinancement comprenant une nouvelle facilité de prêt terme B de 2,325 milliards de dollars (augmentée de 2,2 milliards de dollars), avec un taux d'intérêt Term SOFR + 4,25 %, et une nouvelle facilité de crédit renouvelable de 800 millions de dollars. Ces fonds seront utilisés pour :

  • Rembourser les emprunts en cours sous la facilité de crédit renouvelable existante
  • Refinancer les prêts terme A arrivant à échéance en 2027
  • Refinancer les prêts terme B arrivant à échéance en 2027
  • Payer les frais et dépenses associés

La clôture de l'offre des billets est prévue pour le 26 juin 2025, sous réserve des conditions habituelles. Les billets seront offerts à des acheteurs institutionnels qualifiés aux États-Unis selon la règle 144A et à l'international selon le règlement S, avec des privilèges de premier rang sur les actifs garantissant l'accord de crédit de la société.

Bausch + Lomb gab am 18. Juni 2025 bedeutende Aktivitäten zur Umschuldung bekannt. Das Unternehmen hat die Preisfestsetzung für eine Emission von 675 Millionen Euro vorrangigen besicherten variabel verzinslichen Schuldverschreibungen mit Fälligkeit 2031 vorgenommen, die von ursprünglich angekündigten 600 Millionen Euro erhöht wurde. Die Schuldverschreibungen werden zu 99,500% des Nennwerts verkauft.

Das Unternehmen verfolgt zudem ein Refinanzierungspaket, das eine neue Term-B-Darlehensfazilität über 2,325 Milliarden US-Dollar (erhöht von 2,2 Milliarden US-Dollar) mit einem Zinssatz von Term SOFR + 4,25% sowie eine neue revolvierende Kreditfazilität über 800 Millionen US-Dollar umfasst. Diese Mittel werden verwendet für:

  • Tilgung ausstehender Verbindlichkeiten aus der bestehenden revolvierenden Kreditfazilität
  • Refinanzierung von Term-A-Darlehen mit Fälligkeit 2027
  • Refinanzierung von Term-B-Darlehen mit Fälligkeit 2027
  • Zahlung von damit verbundenen Gebühren und Ausgaben

Die Anleiheemission soll am 26. Juni 2025 abgeschlossen werden, vorbehaltlich üblicher Bedingungen. Die Schuldverschreibungen werden qualifizierten institutionellen Käufern in den USA gemäß Rule 144A und international gemäß Regulation S angeboten, mit vorrangigen Sicherheiten auf Vermögenswerte, die die Kreditvereinbarung des Unternehmens absichern.

Positive
  • Successfully increased Notes offering size from €600M to €675M, indicating strong investor demand
  • Secured larger New Term B Loan Facility of $2.325B (up from previously announced $2.2B)
  • Comprehensive refinancing package includes new $800M revolving credit facility, improving liquidity position
Negative
  • Higher interest costs with New Term B Loan at Term SOFR + 4.25%, potentially impacting profitability
  • Taking on substantial new debt with €675M Notes and $2.325B Term Loan, increasing leverage
  • Notes being sold at slight discount (99.500% of principal), indicating some pricing pressure

Insights

Analyzing...

Bausch + Lomb ha annunciato il 18 giugno 2025 importanti attività di rifinanziamento del debito. La società ha fissato il prezzo di un'emissione di obbligazioni senior garantite a tasso variabile per 675 milioni di euro con scadenza 2031, aumentata rispetto ai 600 milioni di euro inizialmente annunciati. Le obbligazioni saranno vendute al 99,500% del valore nominale.

La società sta inoltre perseguendo un pacchetto di rifinanziamento che include una nuova linea di prestito term B da 2,325 miliardi di dollari (incrementata rispetto ai 2,2 miliardi di dollari precedenti) con un tasso di interesse Term SOFR + 4,25%, e una nuova linea di credito revolving da 800 milioni di dollari. Questi fondi saranno utilizzati per:

  • Rimborsare i prestiti in essere sotto la linea di credito revolving esistente
  • Rifinanziare i prestiti term A in scadenza nel 2027
  • Rifinanziare i prestiti term B in scadenza nel 2027
  • Pagare le commissioni e le spese correlate

L'offerta delle obbligazioni è prevista per la chiusura il 26 giugno 2025, soggetta a condizioni consuete. Le obbligazioni saranno offerte a investitori istituzionali qualificati negli Stati Uniti ai sensi della Rule 144A e a livello internazionale secondo il Regulation S, con privilegi di primo grado sugli asset a garanzia dell'accordo di credito della società.

Bausch + Lomb anunció el 18 de junio de 2025 importantes actividades de refinanciamiento de deuda. La compañía ha fijado el precio de una emisión de notas senior garantizadas a tasa flotante por €675 millones con vencimiento en 2031, incrementado desde los €600 millones inicialmente anunciados. Las notas se venderán al 99.500% del valor nominal.

La empresa también está gestionando un paquete de refinanciamiento que incluye una nueva línea de préstamo a plazo B de $2.325 mil millones (incrementada desde $2.2 mil millones) con una tasa de interés Term SOFR + 4.25%, y una nueva línea de crédito revolvente de $800 millones. Estos fondos se utilizarán para:

  • Reembolsar préstamos pendientes bajo la línea de crédito revolvente existente
  • Refinanciar préstamos a plazo A con vencimiento en 2027
  • Refinanciar préstamos a plazo B con vencimiento en 2027
  • Pagar honorarios y gastos relacionados

Se espera que la oferta de notas cierre el 26 de junio de 2025, sujeta a condiciones habituales. Las notas se ofrecerán a compradores institucionales calificados en EE. UU. bajo la Regla 144A y a nivel internacional bajo el Reglamento S, con gravámenes prioritarios sobre los activos que aseguran el acuerdo crediticio de la compañía.

Bausch + Lomb은 2025년 6월 18일에 중요한 부채 재융자 활동을 발표했습니다. 회사는 2031년 만기 6억 7,500만 유로 규모의 선순위 담보 변동금리 채권 발행 가격을 기존 6억 유로에서 상향 조정하여 확정했습니다. 해당 채권은 액면가의 99.500%에 판매될 예정입니다.

또한 회사는 22억 5천만 달러에서 증액된 23억 2,500만 달러 규모의 신규 Term B 대출 시설 (이자율 Term SOFR + 4.25%)과 8억 달러 규모의 신규 리볼빙 신용 한도를 포함하는 재융자 패키지를 추진 중입니다. 이 자금은 다음 용도로 사용됩니다:

  • 기존 리볼빙 신용 한도 내 미지급 차입금 상환
  • 2027년 만기 Term A 대출 재융자
  • 2027년 만기 Term B 대출 재융자
  • 관련 수수료 및 비용 지급

채권 발행은 2025년 6월 26일에 마감될 예정이며, 통상적인 조건이 적용됩니다. 채권은 미국 내 Rule 144A에 따른 적격 기관 투자자에게, 국제적으로는 Regulation S에 따라 제공되며, 회사 신용 계약을 담보하는 자산에 대해 우선 담보권이 설정됩니다.

Bausch + Lomb a annoncé le 18 juin 2025 d'importantes opérations de refinancement de dette. La société a fixé le prix d'une émission de 675 millions d'euros de billets seniors garantis à taux variable échéance 2031, portée à 675 millions d'euros contre 600 millions initialement annoncés. Les billets seront vendus à 99,500 % de leur valeur nominale.

La société poursuit également un plan de refinancement comprenant une nouvelle facilité de prêt terme B de 2,325 milliards de dollars (augmentée de 2,2 milliards de dollars), avec un taux d'intérêt Term SOFR + 4,25 %, et une nouvelle facilité de crédit renouvelable de 800 millions de dollars. Ces fonds seront utilisés pour :

  • Rembourser les emprunts en cours sous la facilité de crédit renouvelable existante
  • Refinancer les prêts terme A arrivant à échéance en 2027
  • Refinancer les prêts terme B arrivant à échéance en 2027
  • Payer les frais et dépenses associés

La clôture de l'offre des billets est prévue pour le 26 juin 2025, sous réserve des conditions habituelles. Les billets seront offerts à des acheteurs institutionnels qualifiés aux États-Unis selon la règle 144A et à l'international selon le règlement S, avec des privilèges de premier rang sur les actifs garantissant l'accord de crédit de la société.

Bausch + Lomb gab am 18. Juni 2025 bedeutende Aktivitäten zur Umschuldung bekannt. Das Unternehmen hat die Preisfestsetzung für eine Emission von 675 Millionen Euro vorrangigen besicherten variabel verzinslichen Schuldverschreibungen mit Fälligkeit 2031 vorgenommen, die von ursprünglich angekündigten 600 Millionen Euro erhöht wurde. Die Schuldverschreibungen werden zu 99,500% des Nennwerts verkauft.

Das Unternehmen verfolgt zudem ein Refinanzierungspaket, das eine neue Term-B-Darlehensfazilität über 2,325 Milliarden US-Dollar (erhöht von 2,2 Milliarden US-Dollar) mit einem Zinssatz von Term SOFR + 4,25% sowie eine neue revolvierende Kreditfazilität über 800 Millionen US-Dollar umfasst. Diese Mittel werden verwendet für:

  • Tilgung ausstehender Verbindlichkeiten aus der bestehenden revolvierenden Kreditfazilität
  • Refinanzierung von Term-A-Darlehen mit Fälligkeit 2027
  • Refinanzierung von Term-B-Darlehen mit Fälligkeit 2027
  • Zahlung von damit verbundenen Gebühren und Ausgaben

Die Anleiheemission soll am 26. Juni 2025 abgeschlossen werden, vorbehaltlich üblicher Bedingungen. Die Schuldverschreibungen werden qualifizierten institutionellen Käufern in den USA gemäß Rule 144A und international gemäß Regulation S angeboten, mit vorrangigen Sicherheiten auf Vermögenswerte, die die Kreditvereinbarung des Unternehmens absichern.

false 0001860742 Bausch and Lomb Corporation 0001860742 2025-06-18 2025-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

June 18, 2025

Date of Report (Date of the earliest event reported)

 

 

 

Bausch + Lomb Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Canada   001-41380   98-1613662

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

520 Applewood Crescent

Vaughan, Ontario

Canada L4K 4B4

(Address of Principal Executive Offices)(Zip Code)

 

(905) 695-7700

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Shares, No Par Value   BLCO   New York Stock Exchange, Toronto Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 8.01   Other Events.

 

Secured Notes Offering

 

On June 18, 2025, Bausch + Lomb Corporation (the “Company” or “Bausch + Lomb”) announced that its subsidiaries, Bausch & Lomb Incorporated, a New York corporation (the “U.S. Co-Issuer”), and Bausch+Lomb Netherlands B.V. a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands (the “Dutch Co-Issuer” and, together with U.S. Co-Issuer, the “Issuers”), priced the offering of €675 million aggregate principal amount of senior secured floating rate notes due 2031 (“Notes”). The size of the offering was increased from the previously announced €600 million aggregate principal amount of Notes. The Notes will be sold to investors at a price of 99.500% of the principal amount thereof.

 

As previously announced, the Company is also seeking to partially refinance its credit agreement, whereby the Company intends to obtain a $2.325 billion new term B loan facility (the “New Term B Loan Facility”) and a new $800 million revolving credit facility (the “New Revolving Credit Facility”). The New Term B Loan is expected to accrue interest at a rate of Term SOFR + 4.25% per annum. The allocated size of the New Term B Loan Facility was increased from the previously announced $2.2 billion. The Company intends to use the net proceeds from the Notes offering and the New Term B Loan Facility to repay in full the outstanding borrowings under its existing revolving credit facility, to refinance in full its outstanding term A loans due 2027 and term B loans due 2027 and to pay related fees and expenses.

 

The closing of the Notes offering is not contingent upon the closing of the New Term B Loan Facility or the New Revolving Credit Facility.

 

The Notes will be guaranteed by the Company and each of the Company’s subsidiaries (other than the Issuers) that are guarantors under the Company’s credit agreement and will be secured on a first priority basis by liens on the same assets that secure the obligations under the Company’s credit agreement and the Company’s 8.375% senior secured notes due 2028.

 

Closing of the Notes offering is expected to occur on June 26, 2025, subject to customary closing conditions.

 

The Notes are being offered in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.

 

The New Term B Loan Facility and New Revolving Credit Facility are also expected to close on June 26, 2025; however, there can be no assurances that the Company will be able to complete the New Term B Loan Facility and/or New Revolving Credit Facility transactions on the terms described above or at all. 

 

The Company also issued a press release pursuant to Rule 135c under the Securities Act relating to the offering of the Notes. In accordance with Rule 135c(d) under the Securities Act, a copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated herein by reference.

 

The foregoing is qualified by reference to the press release attached as Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated herein by reference.

 

This Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 do not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.

 

 

 

Item 9.01   Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit 

Number 

  Description
     
99.1   Press Release of Bausch + Lomb Corporation, announcing the pricing of the Notes offering, dated June 18, 2025
     
104   Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BAUSCH + LOMB CORPORATION
     
     
  By: /s/ Sam Eldessouky
  Name: Sam Eldessouky
  Title: Executive Vice President, Chief Financial Officer

 

Date: June 18, 2025

 

 

FAQ

How much debt is BLCO raising in its new Notes offering announced on June 18, 2025?

BLCO announced pricing of €675 million aggregate principal amount of senior secured floating rate notes due 2031, which was increased from the previously announced €600 million. The Notes will be sold to investors at 99.500% of the principal amount.

What is the size of BLCO's new Term B Loan Facility and what is its interest rate?

BLCO is seeking a $2.325 billion new Term B Loan Facility (increased from previously announced $2.2 billion) with an interest rate of Term SOFR + 4.25% per annum, along with a new $800 million revolving credit facility.

How will BLCO use the proceeds from its 2025 Notes offering and Term B Loan?

BLCO will use the net proceeds to: 1) repay outstanding borrowings under existing revolving credit facility, 2) refinance in full its outstanding term A loans due 2027 and term B loans due 2027, and 3) pay related fees and expenses.

When is BLCO's new debt offering expected to close?

The Notes offering and the New Term B Loan Facility and New Revolving Credit Facility are all expected to close on June 26, 2025, subject to customary closing conditions. However, the company notes that the Notes offering closing is not contingent upon the closing of the loan facilities.

Who can purchase BLCO's new Notes offering?

The Notes are being offered in the United States to qualified institutional buyers under Rule 144A of the Securities Act, and to non-U.S. persons outside the United States under Regulation S. In Canada, the Notes will be sold on a basis exempt from prospectus requirements.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

4.15B
41.33M
88.41%
10.27%
0.53%
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN